drugset / Trial / NCT05065164

Denosumab and Screw Fixation for Osteoporotic Compression Fracture

NCT05065164

Phase 2/3 Withdrawn Shenzhen People's Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Evaluation of bone mineral density and function at 1 year after screw internal fixation of osteoporotic vertebral compression fractures with desuzumab: a parallel double-blind randomized controlled clinical trial

Timeline

Start
2021-09-14
Primary completion
2023-03-20
Completion
2023-09-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Denosumab Monoclonal antibody 60 mg Subcutaneous

Indications